Tech firms group acquires healthcare software provider
Shipley-based business e-clinic, a patient and clinic management software provider, has been acquired by a group of technology companies.
ClearCourse Partnership, which offers software, services and digital capabilities to the membership, events and bookings and sports and leisure sectors, confirmed it had bought e-clinic which employs seven people and has been operating since 2002. The deal is ClearCourse’s 13th since it was founded in October 2018.
A spokesman for ClearCourse said the acquisition represented an expansion of the group’s products into the healthcare industry.
He added: “ClearCourse will work closely with e-clinic’s senior team, providing operational expertise and financial resources to bolster and support the company’s ambitious growth strategy and continued platform development.
“e-clinic will also gain access to improved payments infrastructure and other technology products, including data validation services, from within the Partnership.”
e-clinic’s own proprietary, cloud-based software package, called “e-clinic 2”, is used by clients across the world. These range from small, private medical practices to larger multi-disciplinary clinics and hospitals.
Gerry Gualtieri, CEO of ClearCourse, said: “e-clinic is a dynamic new addition to ClearCourse Partnership. The company has developed a strong reputation in the healthcare sector for delivering first-class management solutions to an impressive list of clients around the world.
“We see great opportunities for commercial synergies between e-clinic and the wider Partnership, particularly around the provision of payments and membership management tools.
“We’re excited to work closely with the team to realise those synergies and support the company’s continued growth and development.”
Mark Lainchbury, Managing Director of e-clinic, added: “We’re very proud to have built e-clinic into the highly successful, market-leading business that it is today.
“By joining the ClearCourse Partnership, we have access to a valuable range of resources and operational expertise that will allow us to continue to grow, develop and realise our ambitious plans for the future.
“We remain dedicated to creating the best possible product for our clients, so we can continue to improve patient care around the world.”